Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mosaic HIV-1 Envelope Trimer Immunogens in adults living with HIV in Africa
PACTR202407739287108Phase 1Not yet recruiting
- Sponsor
- International AIDS Vaccine Initiative
- Start
- Aug 2024
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
Phase 1 trial of mosaic HIV-1 envelope trimer immunogens in human immunodeficiency virus infection (HIV) (2 arms), sponsored by International AIDS Vaccine Initiative. Primary endpoints: Safety and tolerability, Moderate or greater reactogenicity and 2 more. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
mosaic HIV-1 envelope trimer immunogens
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on PACTR202407739287108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202407739287108.